Safety and Immunogenicity of the Recombinant BCG Vaccine AERAS-422 in Healthy BCG-naïve Adults: A Randomized, Active-controlled, First-in-human Phase 1 Trial
published in: EBioMedicine
date of publication: 2016-04-19
main subject: phase I clinical trial, BCG vaccine
Cites articles 29
Date
Title
Article - wd:Q37008729